Healthcare

The objective of this study is to present a comprehensive landscape of cardiac cathlabs in Europe, with respect to total PCI centres, pPCI centres, and key trends. The regional scope of this analysis is focused on major European countries, including Western European countries such as the United Kingdom, Germany, France, Italy, and Spain. The Easter...

This study covers the global market for visible light (VL) imaging informatics and operating room (OR) imaging informatics. The latter pertain to digital and integrated operating rooms having intra-operative imaging capabilities, which are driven by increasing adoption of image-guided surgery (IGS) and minimally invasive surgery (MIS) techniques. T...

Intensive care units (ICUs) are primarily for managing patients with acute or lifethreatening disease or conditions. The critical care provided in the ICUs depends upon the resource availability such as skilled personnel and reliable advanced therapeutic and monitoring equipments. Hence, ICUs contribute to a significant amount of spending despite b...

This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

29 Mar 2016  |  Global  |  Market Research

Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative

Multi-billion dollar technologies ready to propel industries and transform our world

Infographics

×

Research Overview The Top 50 Emerging Technologies research is a comprehensive analysis of the most promising and disruptive technologies poised to impact our world in the next few years. It highlights and offers strategic guidance and actionable ideas on the hottest 50 technologies that pack maximum potential to fuel global innovation; spawn in...

As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...

The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...

This issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.

The total market, as defined by this study, includes automated robotic workstations, low-to-mid throughput automated tools, and manual pipettes and consumables in the United States. The study period runs from 2011 to 2021, with 2014 as base year of 2014 and 20152021 as forecast period. This research service offers a discussion of the key market dr...